Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2008
11/27/2008US20080293663 Cellular genes regulated by hiv-1 infection and methods of use thereof
11/27/2008US20080293660 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/27/2008US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
11/27/2008US20080293657 Modulation of the expression of stat-1-dependent genes
11/27/2008US20080293654 Therapeutic methods using Smads
11/27/2008US20080293652 Combination of Ad-P53 and Chemotherapy for the Treatment of Tumours
11/27/2008US20080293641 Biologically active peptides
11/27/2008US20080293640 Polypeptide inhibitors of HSP27 kinase and uses therefor
11/27/2008US20080293639 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
11/27/2008US20080293638 Albumin-fused ciliary neurotrophic factor
11/27/2008US20080293637 Cross-linked collagen and uses thereof
11/27/2008US20080293636 Protein Constructs Designed for Targeting and Lysis of Cells
11/27/2008US20080293635 Angiogenic composition
11/27/2008US20080293634 C-met receptor regulation by angiotensin iv (at4) receptor ligands
11/27/2008US20080293633 Pharmaceutical Formulations, Methods, and Dosing Regimens for the Treatment and Prevention of Acute Coronary Syndromes
11/27/2008US20080293632 Use of natriuretic peptides for the treatment of stature disorders related to shox gene
11/27/2008US20080293631 Treatment for Autoimmune and Inflammatory Conditions
11/27/2008US20080293630 Mucoadhesive Pharmaceutical Compositions Comprising Chemoattractants
11/27/2008US20080293629 Albumin Fusion Proteins
11/27/2008US20080293628 Methods and Compositions for the Inhibition of Thrombus Formation
11/27/2008US20080293627 Thyrotropin Receptor Preparations, Binding Regions Thereof, Antibody and Hormone Interactions Therewith, and Uses Thereof
11/27/2008US20080293626 Pigment epithelium-derived factor as a therapeutic agent for vascular leakage
11/27/2008US20080293625 Diagnosis of Inflammatory Bowel Diseases, More Particularly Ulcerative Colitis
11/27/2008US20080293624 Stabilized FGF formulations containing reducing agents
11/27/2008US20080293623 Enriched haptoglobin polymers for the treatment of disease
11/27/2008US20080293622 Methods of inducing ovulation
11/27/2008US20080293621 Methods for Prolonging Feline Life
11/27/2008US20080293620 Immunogenic Glycopeptides for Diagnosing Pathogenic Microorganisms Infections
11/27/2008US20080293619 Compositions and methods for treating malaria with cupredoxin and cytochrome
11/27/2008US20080293618 Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase iv inhibitors
11/27/2008US20080293617 Implantable Putty Material
11/27/2008US20080293163 Methods to identify compounds that modulate rage
11/27/2008US20080293121 Human dnase i hyperactive variants
11/27/2008US20080293116 Ovary-specific genes and proteins
11/27/2008US20080293103 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
11/27/2008US20080293077 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses
11/27/2008US20080292828 Composition Comprising Various Proteorhodopsins and/or Bacteriorhodopsins and Use Thereof
11/27/2008US20080292750 Method of Preparing a Food Ingredient and Food Product Having Angiotensin-I-Converting Enzyme Inhibiting Properties and Products Thus Obtained
11/27/2008US20080292724 Composition for improving membrane composition and functioning cells
11/27/2008US20080292712 Methods and compositions for enhanced delivery of bioactive molecules
11/27/2008US20080292704 Methods and Compositions Involving Polymeric Immunoglobulin Fusion Proteins
11/27/2008US20080292691 Bariatric magnetic apparatus and method of manufacturing thereof
11/27/2008US20080292687 Methods of Treating Cancer and Other Conditions or Disease States Using Lfmau and Ldt
11/27/2008US20080292682 Method for treating allergic dermatitis
11/27/2008US20080292678 Medical articles having enzymatic surfaces for localized therapy
11/27/2008US20080292675 Antimicrobial medicotechnical product, process for its production and use
11/27/2008US20080292668 Water-Free Cosmetic Preparation
11/27/2008US20080292661 Use of Botulinum Toxin for the Preparation of a Medicament for the Treatment of Lithiasis of Salivary Gland, Gall Bladder, Kidney, or Pancreas
11/27/2008US20080292654 Human Bocavirus and Methods of Diagnosis and Treatment
11/27/2008US20080292650 Therapeutic and diagnostic peptides
11/27/2008US20080292647 immunogenic protein in a biodrug, was encoded from an isolated host cell transfected with the recombinant expression vector; anticarcinogenic agent for treating skin cancer; vaccine for prevention and treatment; immunotherapy
11/27/2008US20080292643 Leukocyte inactivation module
11/27/2008US20080292636 Chemokine panec-2 polynuleotides, polypeptides, antibodies and methods of making and using them
11/27/2008US20080292635 Allergenic latex protein
11/27/2008US20080292634 Nontypable Haemophilus Infuenzae Virulence Factors
11/27/2008US20080292633 Compositions and methods for the therapy and diagnosis of lung cancer
11/27/2008US20080292628 Chimeric Protein
11/27/2008US20080292627 Compositions and Methods for Treating Mood and Anxiety Disorders
11/27/2008US20080292623 Mammalian cell membrane proteins; related reagents
11/27/2008US20080292618 Intranuclear protein transduction through a nucleoside salvage pathway
11/27/2008US20080292616 Topical Formulations of Histone Deacetylase Inhibitors and Methods Using the Same
11/27/2008US20080292615 Diagnosis and treatment of disease
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292613 Food Supplement Based on Group B Vitamins, Trace Elements and -3 and/or 6- Fatty Acids and Use of This Food Supplement in the Simultaneous Treatment of Localized Cellulite and Slackening of the Skin
11/27/2008US20080292612 Composition containing several botulic toxins
11/27/2008US20080292611 Novel methods of treatment and delivery modes
11/27/2008US20080292610 Medicaments containing enzymes from ciliates for promoting digestion in digestive disorders
11/27/2008US20080292609 Use of Arginase in Combination with 5FU and Other Compounds for Treatment of Human Malignancies
11/27/2008US20080292608 Compounds and Compositions as Ppar Modulators
11/27/2008US20080292602 T Cell Receptors Which Specifically Bind to Vygfvracl-Hla-A24
11/27/2008US20080292590 Multiple Sclerosis; use of soluble interleukin (IL)-18R;
11/27/2008US20080292589 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
11/27/2008US20080292588 hepatitis C virus; 5-(4-fluoro-benzyl)-8-hydroxy-7-(1-methyl-1 oxo-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-5-aza-spiro[2.5]oct-7-en-6-one
11/27/2008US20080292587 Oximyl dipeptide hepatitis c protease inhibitors
11/27/2008US20080292586 Method and Use of Interferon Compositions For the Treatment of Avian Influenza
11/27/2008US20080292585 Azonafide Derivatives, Methods for Their Production and Pharmaceutical Compositions Therefrom
11/27/2008US20080292584 Metaxalone products, method of manufacture, and method of use
11/27/2008US20080292583 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione following autologous stem cell transplantation
11/27/2008US20080292582 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
11/27/2008US20080292581 Interleukin-11 Fusion Proteins
11/27/2008US20080292568 3-Deoxyglucosone and skin
11/27/2008US20080292549 High Affinity Melan-A T Cell Receptors
11/27/2008US20080292548 Compounds and methods for 18f labeled agents
11/27/2008US20080292545 Functionalized Encoded Apoferritin Nanoparticles and Processes for Making and Using Same
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008US20080290328 Photochromic Material Comprising a Proteorhodopsin Apoprotein and a Retinal Analog
11/27/2008DE10251709B4 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3
11/27/2008DE102007024802A1 Use of an active substance mixture comprising a fraction specific peptide and fraction essential and non-essential amino acids for the production of a composition to treat, prophylaxis and/or metaphylaxis of e.g. dementia disease
11/27/2008CA2724833A1 Use of seleneium yeast composition for establishing and/or maintaining pregnancy
11/27/2008CA2688554A1 Dose forms comprising vx-950 and their dosage regimen
11/27/2008CA2688536A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
11/27/2008CA2687602A1 Peptides with improved properties having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases
11/27/2008CA2687534A1 Method for production of dendritic cell
11/27/2008CA2687493A1 Recombinant protein production in avian ebx r cells
11/27/2008CA2684946A1 Treatment of synucleinopathies
11/27/2008CA2684885A1 Preparative purification process for human furin
11/27/2008CA2684758A1 Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof
11/27/2008CA2684604A1 Methods and compositions for treating skin conditions
11/27/2008CA2684151A1 Method for producing mature vwf from vwf pro-peptide
11/27/2008CA2683935A1 An extended-release composition comprising a somatostatin derivative in microparticles
1 ... 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 ... 3163